CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 14 No. 8
The Wexner/Hwang Article Reviewed 

Clinical Status of Laparoscopic Bowel Surgery for GI Malignancy

By

Robert Talac, MD, PhD, and Heidi Nelson, MD, FACS, Divison of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota

| August 1, 2000

Laparoscopic surgery for colorectal malignancy is an important topic because of its potential advantages and its oncologic controversies. Drs. Wexner and Hwang have prepared a comprehensive review of the current status of laparoscopic colorectal surgery for malignancy. The relative merits of the new procedure are discussed from a number of perspectives, including the technical aspects of laparoscopic bowel resection, oncologic concerns, and experimental and theoretical effects on tumor growth and host immunity.

Considering the fact that laparoscopic surgery for malignancy is relatively new and has some degree of variability, interpretation of the available data regarding particular issues requires sound judgment and experience. A few issues are highlighted below.

Safety of Laparoscopic Surgery

First, can laparoscopic colectomy be performed with acceptable rates of morbidity and mortality? An evaluation of efficacy is reasonable only if the new procedure is proven to be safe in general practice. As initial reports provided either no comparison with the open technique or used historical controls, an assessment of the safety of laparoscopic colectomy has not been an easy task. Moreover, early reports reflected the developing period of laparoscopic colorectal surgical technique. Therefore, comparisons of the preliminary results of the laparoscopic approach with the well-established open technique were confusing and potentially misleading.

Most recently reported data have shown a decrease in the incidence of wound-related complications—eg, infections and hernias, intra-abdominal adhesions, and small bowel obstructions—in patients treated by laparoscopic colectomy.[1,2] In general, laparoscopic colectomy is considered as safe as open colectomy.

Age is a significant variable in the outcome of surgery. Thus, the safety and benefit of laparoscopic colectomy are of critical importance for elderly patients. Recently, Stocchi et al reported that laparoscopic colectomy is not only safe in patients over 75 years old, but its benefits are more striking in this age group than in the general population.[3]

Another important issue related to safety is technical competence. Laparoscopic bowel resection is only a modification of the previous treatment standard, ie, laparotomy. We prefer the laparoscopic-assisted technique, as do Drs. Wexner and Hwang, especially for resections of the right and left colon. The laparoscopic-assisted approach resulted in significant simplification of the procedure as well as shorter operative time, shorter learning curve, and a decrease in the conversion rate and laparoscopy-related complications.

Resection of Malignant Tumors

The laparoscopic resection of malignant tumors entails additional concerns. As the authors point out, correct staging of disease is an important principle of cancer management. Laparoscopic inspection of the surfaces of intraperitoneal organs and the peritoneal cavity is certainly possible, but palpation is not. Therefore, additional studies must supplement the laparoscopic bowel resection.

Although preliminary experience with laparoscopic intraoperative ultrasound suggests that this technology has the potential to provide more accurate staging and probably should become a standard component of curative laparoscopic resection for malignancy, studies on the feasibility of laparoscopic ultrasound are pending. Whether laparoscopic inspection of the liver and external imaging with computed tomography or ultrasound are equivalent to intra-abdominal palpation has yet to be determined by prospective randomized trials of laparoscopic and open colectomy.

The most important issue is long-term oncologic outcome—specifically, 5-year survival and disease-free interval. The paucity of evidence on these parameters precludes any definitive conclusion regarding the advisability of a laparoscopic approach for colorectal cancer. In the absence of long-term data, surrogate clinical and pathologic parameters have been evaluated to determine the appropriateness of the laparoscopic approach for curative cancer resection. These parameters include proximal and distal resection margins, lymph node yields, and level of vascular pedicle ligation.

In colon cancer patients, data have shown conclusively that an equivalent specimen can be retrieved using the laparoscopic approach.[4,5] Resection of rectal cancer presents additional challenges, ie, achieving adequate circumferential margins and pelvic dissection in the correct anatomic plane. Although, rectal dissection to the level of the levators is possible, it is not known whether the extent of laparoscopic rectal resection is adequate.[6]

Port Site Metastases

Any appraisal of laparoscopic bowel surgery must include consideration of port site metastases. The authors state that the possibility of port site metastases remains the major contraindication for laparoscopic excision of colon cancer and that the estimated incidence of port site metastases ranges from 0% to 21%. Although this problem alone is good reason for careful testing of the new procedure, the main reason for avoiding laparoscopic colectomy outside of clinical trials is that data on long-term outcome are not yet available. Patients with cancer may not value the advantages of this minimally invasive approach if outcomes are compromised.

Drs. Wexner and Hwang do not elaborate on the data regarding incidence of port site metastases that have become available over the past 8 years. Early estimates of incidence were difficult to obtain, and were reported to range from 0% to 21%. These early studies, however, suffered from the same problems as the safety assessments—they reflected a period of developing technique and relative inexperience that resulted in technical mishaps.

More recent studies performed by experienced laparoscopic surgeons suggest that the rate of port site recurrences is more realistically between 0% and 1.4%.[1,5] This is comparable to the incidence rates reported for open colectomy, which range from 0.6% to 2.5%.[1,7,8] Although there is a paucity of information on the etiology of port site recurrences, the fact that wound implants are absent in some series suggest that this phenomenon is probably related to the technical details of performing the procedure and not necessarily an inevitable consequence of the pneumoperitoneal technique.

Quality of Life

Finally, the appraisal of the clinical status of laparoscopic surgery for colorectal cancer should include information on the impact of the laparoscopic approach on quality of life. A number of studies have shown reductions in postoperative pain, postoperative ileus, hospital stay, and overall recovery.[2] Although formal studies evaluating quality of life after laparoscopic and open colectomy for cancer have not been conducted, it is reasonable to suggest that less postoperative pain and fatigue and a shorter hospital stay positively influence duration of recovery and quality of life. Considering the increasing emphasis on broader definitions of health outcomes, these issues will certainly have a significant impact on the overall acceptance of laparoscopic colorectal surgery for malignancy.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.



Steven D. Wexner, MD, FACS, FRCS, FRCS (Ed) and Yong-Hee Hwang, MD


1. Talac R, Nelson H: Laparoscopic colon and rectal surgery. Surg Oncol Clin North Am 9(1):1, 2000.

2. Young-Fadok TM, Talac R, Nelson H: Laparoscopic colectomy: The need for clinical trials. Semin Colon Rectal Surg 10(2):94, 1999.

3. Stocchi L, Nelson H, Young-Fadok TM, et al: Safety and advantages of laparoscopic vs open colectomy in the elderly: Matched-control study. Dis Colon Rectum 43(3):326, 2000.

4. Fleshman JW, Nelson H, Peters WR, et al: Early results of laparoscopic surgery for colorectal cancer: Retrospective analysis of 372 patients treated by Clinical Outcome of Surgical Therapy (COST) Study Group. Dis Colon Rectum 39(suppl 10):S53-S58, 1996.

5. Franklin ME, Rosenthal D, Abreago-Medina D, et al: Prospective comparison of open vs laparoscopic colon surgery for carcinoma: Five-year results. Dis Colon Rectum 39:35, 1996.

6. Darzi A, Lewis C, Menzies-Gow N, et al: Laparoscopic abdominoperineal resection of the rectum. Surg Endosc 9:414, 1995.

7. Stocchi L, Nelson H: Abdominal wall recurrences after open surgery, in Reymond MA, Bonjer HJ, Köckerling F (eds): Port-Site Recurrences: Incidence-Pathogenesis-Prevention, pp 8-11. Springer, New York, 2000.

8. Reilly WT, Nelson H, Schroeder G, et al: Wound recurrence following conventional treatment of colorectal cancer: A rare but perhaps underestimated problem. Dis Colon Rectum 39(2):200, 1996.


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 52-Year-Old Man Presents With an Erythematous Lesion
Cesar Moran, MD , May 22, 2013

A 52-year-old man presented with an erythematous lesion in the axilla of unknown duration. Surgical excision was performed. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy